Hikma Pharmaceuticals Plc Annual Information Update (5115U)
April 07 2016 - 6:41AM
UK Regulatory
TIDMHIK
RNS Number : 5115U
Hikma Pharmaceuticals Plc
07 April 2016
Hikma Pharmaceuticals PLC
Annual Information Update
London, 7 April 2016. In accordance with Prospectus Rule 5.2,
Hikma Pharmaceuticals PLC ("Hikma" or "the Company") (LSE: HIK)
sets out below a summary of the information which has been
published or made available to the public over the period. In
accordance with Prospectus Rule 5.2.7, it is acknowledged that
whilst the information referred to in this update was up to date at
the time of publication, such disclosures may, at any time, become
out of date due to changing circumstances.
Stock Exchange Announcements
Announcements made by the Company via RNS, a Regulatory
Information Service, may be viewed and downloaded from the
Company's market news section on the London Stock Exchange website
at
(http://www.londonstockexchange.com/prices-and-news/stocks/stocks-and-prices.htm)
or from the press releases page on the Company's website at
(http://www.hikma.com/investorrelations/rns/). The Stock Exchange
announcements made during the period were:
Date Headline
----------- ----------------------------------
07/04/2016 Annual Financial Report
----------- ----------------------------------
06/04/2016 Blocklisting Interim Review
----------- ----------------------------------
05/04/2016 Director/PDMR Shareholding
----------- ----------------------------------
31/03/2016 Director/PDMR Shareholding
----------- ----------------------------------
29/03/2016 Director/PDMR Shareholding
----------- ----------------------------------
21/03/2016 Director/PDMR Shareholding
----------- ----------------------------------
17/03/2016 Director/PDMR Shareholding
----------- ----------------------------------
16/03/2016 Final Results
----------- ----------------------------------
03/03/2016 Notice of Results
----------- ----------------------------------
29/02/2016 Holding(s) in Company
----------- ----------------------------------
29/02/2016 Holding(s) in Company
----------- ----------------------------------
29/02/2016 Total Voting Rights
----------- ----------------------------------
29/02/2016 Roxane Acquisition Close
----------- ----------------------------------
22/02/2016 Directorate Change
----------- ----------------------------------
19/02/2016 EGM Statement
----------- ----------------------------------
11/02/2016 Holding(s) in Company
----------- ----------------------------------
11/02/2016 Circ re. Roxane Acquisition
----------- ----------------------------------
10/02/2016 Circ re. Roxane Acquisition
----------- ----------------------------------
Circ re. Roxane Acquisition and
22/01/2016 EGM
----------- ----------------------------------
07/01/2016 Total Voting Rights
----------- ----------------------------------
Shareholders' Agreement and Board
24/12/2015 Appointment
----------- ----------------------------------
17/12/2015 Total Voting Rights
----------- ----------------------------------
03/12/2015 Director/PDMR Shareholding
----------- ----------------------------------
Hikma announces sale of Ben Venue
25/11/2015 manufacturing
----------- ----------------------------------
24/11/2015 Holding(s) in Company
----------- ----------------------------------
18/11/2015 Resolution to FDA Warning Letter
----------- ----------------------------------
16/11/2015 Holding(s) in Company
----------- ----------------------------------
11/11/2015 Holding(s) in Company
----------- ----------------------------------
10/11/2015 Holding(s) in Company
----------- ----------------------------------
02/11/2015 Trading Statement
----------- ----------------------------------
22/10/2015 Block Listing of Share
----------- ----------------------------------
19/10/2015 Holding(s) in Company
----------- ----------------------------------
12/10/2015 Blocklisting Interim Review
----------- ----------------------------------
08/10/2015 Total Voting Rights
----------- ----------------------------------
18/09/2015 Audit Tender
----------- ----------------------------------
16/09/2015 Total Voting Rights
----------- ----------------------------------
11/09/2015 Director/PDMR Shareholding
----------- ----------------------------------
27/08/2015 Director/PDMR Shareholding
----------- ----------------------------------
27/08/2015 Director/PDMR Shareholding
----------- ----------------------------------
19/08/2015 Director/PDMR Shareholding
----------- ----------------------------------
19/08/2015 Interim Results
----------- ----------------------------------
28/07/2015 Acquisition
----------- ----------------------------------
14/07/2015 Total Voting Rights
----------- ----------------------------------
18/05/2015 Director/PDMR Shareholding
----------- ----------------------------------
15/05/2015 Director/PDMR Shareholding
----------- ----------------------------------
14/05/2015 Result of AGM
----------- ----------------------------------
14/05/2015 AGM Trading Update
----------- ----------------------------------
15/04/2015 Holding(s) in Company
----------- ----------------------------------
10/04/2015 Total Voting Rights
----------- ----------------------------------
10/04/2015 Director/PDMR Shareholding
----------- ----------------------------------
09/04/2015 Annual Information Update
----------- ----------------------------------
All of the above announcements were also made by the Company via
the Nasdaq Dubai stock exchange CANDI system. These announcements
may be viewed and downloaded from the Nasdaq Dubai website
(www.candi.nasdaq.com).
Documents filed with the Financial Conduct Authority
The Company has filed the following documents with the Financial
Conduct Authority ("FCA") via the National Storage Mechanism over
the previous 12 months. These documents are available at
http://www.hemscott.com/nsm.do or at the Company's registered
office.
Date Document
----------- --------------------------------
07/04/2016 Annual Report and Accounts 2015
----------- --------------------------------
07/04/2016 Notice of 2016 Annual General
Meeting
----------- --------------------------------
07/04/2016 Proxy form for the 2016 Annual
General Meeting
----------- --------------------------------
Documents filed with Companies House
The Company submitted filings to the Registrar of Companies in
England and Wales as detailed in the table below.
Date Filed Form Description
----------- ------------ ---------------------------------
AP01 Appointment of John Julius
Castellani as a director
02/03/2016 on 1 March 2016
----------- ------------ ---------------------------------
SH01 Statement of capital following
an allotment of shares on
29/02/2016 29 February 2016
----------- ------------ ---------------------------------
AP01 Appointment of Jochen Gann
as a director on 29 February
29/02/2016 2016
----------- ------------ ---------------------------------
SH01 Statement of capital following
an allotment of shares on
07/01/2016 7 January 2016
----------- ------------ ---------------------------------
SH01 Statement of capital following
an allotment of shares on
17/12/2015 16 December 2015
----------- ------------ ---------------------------------
SH01 Statement of capital following
an allotment of shares on
09/10/2015 9 October 2015
----------- ------------ ---------------------------------
SH01 Statement of capital following
an allotment of shares on
17/09/2015 17 September 2015
----------- ------------ ---------------------------------
AR01 Annual return made up to
7 September 2015 no member
11/09/2015 list
----------- ------------ ---------------------------------
SH01 Statement of capital following
an allotment of shares on
09/09/2015 19 August 2015
----------- ------------ ---------------------------------
SH01 Statement of capital following
an allotment of shares on
15/07/2015 13 July 2015
----------- ------------ ---------------------------------
AA Group of companies' accounts
10/06/2015 made up to 31 December 2014
----------- ------------ ---------------------------------
RESOLUTIONS RES09 - Resolution of authority
to purchase a number of
shares
RES10 - Resolution of allotment
of securities
RES10 - Resolution of allotment
29/05/2015 of securities
----------- ------------ ---------------------------------
SH01 Statement of capital following
an allotment of shares on
07/04/2015 31 March 2015
----------- ------------ ---------------------------------
Copies of all these documents may be obtained from Companies
House, Crown Way, Maindy, Cardiff CF14 3UZ or, if you are a
registered user, they may be viewed and downloaded using Companies
House "Webcheck" at www.companieshouse.gov.uk.
(MORE TO FOLLOW) Dow Jones Newswires
April 07, 2016 06:41 ET (10:41 GMT)
Documents provided to Shareholders
Further Information
Copies of all documents can be obtained from the Company at the
registered office which is located at 13 Hanover Square, London W1S
1HW.
Peter Speirs
Company Secretary
7 April 2016
- ENDS -
Enquiries:
Hikma Pharmaceuticals
PLC
Peter Speirs
Company Secretary +44 20 7399 2670
About Hikma
Hikma Pharmaceuticals PLC is a fast growing pharmaceutical group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed products.
Hikma's operations are conducted through three businesses:
"Branded", "Injectables" and "Generics" based primarily in the
Middle East and North Africa ("MENA") region, where it is a market
leader, the United States and Europe. In 2015, Hikma achieved
revenues of $1,440 million and profit attributable to shareholders
of $252 million.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBDLFBQZFZBBB
(END) Dow Jones Newswires
April 07, 2016 06:41 ET (10:41 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
